当前位置：
X-MOL 学术
›
Am. J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma: A Retrospective Cohort Study.
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2021-09-01 , DOI: 10.1097/coc.0000000000000861 Lynn E Nooijen 1 , Lotte C Franken 1 , Ali Belkouz 2 , Ikrame Oulad Abdennabi 3 , Marc G Besselink 1 , Olivier R Busch 1 , Rutger-Jan Swijnenburg 1 , Heinz-Josef Klümpen 2 , Joris I Erdmann 1
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2021-09-01 , DOI: 10.1097/coc.0000000000000861 Lynn E Nooijen 1 , Lotte C Franken 1 , Ali Belkouz 2 , Ikrame Oulad Abdennabi 3 , Marc G Besselink 1 , Olivier R Busch 1 , Rutger-Jan Swijnenburg 1 , Heinz-Josef Klümpen 2 , Joris I Erdmann 1
Affiliation
In this retrospective cohort study, the potential of gemcitabine (gem)/cisplatin (cis) chemotherapy as future preoperative therapy for patients with unresectable locally advanced or borderline resectable intrahepatic, perihilar, and mid-cholangiocarcinoma was investigated.
中文翻译：
吉西他滨联合顺铂作为局部晚期肝内、肝门周围和中段胆管癌潜在术前化疗的疗效和安全性：一项回顾性队列研究。
在这项回顾性队列研究中，研究了吉西他滨 (gem)/顺铂 (cis) 化疗作为未来术前治疗对于不可切除的局部晚期或临界可切除的肝内、门周和中段胆管癌患者的潜力。
更新日期：2021-09-01
中文翻译：
吉西他滨联合顺铂作为局部晚期肝内、肝门周围和中段胆管癌潜在术前化疗的疗效和安全性：一项回顾性队列研究。
在这项回顾性队列研究中，研究了吉西他滨 (gem)/顺铂 (cis) 化疗作为未来术前治疗对于不可切除的局部晚期或临界可切除的肝内、门周和中段胆管癌患者的潜力。
京公网安备 11010802027423号